Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.

Autor: Loeschenberger B; Department of Internal Medicine IV, Innsbruck Medical University, Innsbruck, Austria., Niess L; Department of Internal Medicine IV, Innsbruck Medical University, Innsbruck, Austria., Würzner R; Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria., Schwelberger H; Molecular Biology Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria., Eder IE; Department of Urology, Division of Experimental Urology, Innsbruck Medical University, Innsbruck, Austria., Puhr M; Department of Urology, Division of Experimental Urology, Innsbruck Medical University, Innsbruck, Austria., Guenther J; Daniel Swarovski Research Laboratory, Department of Visceral, Transplant- and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria., Troppmair J; Daniel Swarovski Research Laboratory, Department of Visceral, Transplant- and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria., Rudnicki M; Department of Internal Medicine IV, Innsbruck Medical University, Innsbruck, Austria., Neuwirt H; Department of Internal Medicine IV, Innsbruck Medical University, Innsbruck, Austria.
Jazyk: angličtina
Zdroj: European journal of immunology [Eur J Immunol] 2018 Feb; Vol. 48 (2), pp. 330-343. Date of Electronic Publication: 2017 Dec 11.
DOI: 10.1002/eji.201747135
Abstrakt: One factor that significantly contributes to renal allograft loss is chronic calcineurin inhibitor (CNI) nephrotoxicity (CIN). Among other factors, the complement (C-) system has been proposed to be involved CIN development. Hence, we investigated the impact of CNIs on intracellular signalling and the effects on the C-system in human renal tubule cells. In a qPCR array, CNI treatment upregulated C-factors and downregulated SOCS-3 and the complement inhibitors CD46 and CD55. Additionally, ERK1/-2 was required for these regulations. Following knock-down and overexpression of SOCS-3, we found that SOCS-3 inhibits ERK1/-2 signalling. Finally, we assessed terminal complement complex formation, cell viability and apoptosis. Terminal complement complex formation was induced by CNIs. Cell viability was significantly decreased, whereas apoptosis was increased. Both effects were reversed under complement component-depleted conditions. In vivo, increased ERK1/-2 phosphorylation and SOCS-3 downregulation were observed at the time of transplantation in renal allograft patients who developed a progressive decline of renal function in the follow-up compared to stable patients. The progressive cohort also had lower total C3 levels, suggesting higher complement activity at baseline. In conclusion, our data suggest that SOCS-3 inhibits CNI-induced ERK1/-2 signalling, thereby blunting the negative control of C-system activation.
(© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
Databáze: MEDLINE
Externí odkaz: